1 January 2000 | 8256 views | Tags: Health
A collection of technical publications relating to aquatic animal disease prevention, diagnosis and treatment.
Creative Commons Attribution.
NACA publishes a wide range of aquaculture publications including technical manuals, workshop proceedings, better practice guidelines and several serials including Aquaculture Asia Magazine, the NACA Newsletter and the Quarterly Aquatic Animal Disease Report. To keep up to date with developments you could consider subscribing to our free email newsletter service and RSS feed.
In this collection
WHO: Stop using antibiotics in healthy animals to prevent the spread of antibiotic resistance
The World Health Organization (WHO) is recommending that farmers and the food industry stop using antibiotics routinely to promote growth and prevent disease in healthy animals. The new WHO recommendations aim to help preserve the effectiveness of antibiotics that are important for human medicine by reducing their unnecessary use in animals. In some countries, approximately 80% of total consumption of medically important antibiotics is in the animal sector, largely for growth promotion in healthy animals.
Tilapia lake virus (TiLV): Literature review
Tilapia lake virus (TiLV) is an emerging infectious agent that has recently been identified on three continents. While the link between TiLV and disease outbreaks in Israel and Thailand are well documented, further investigations are being undertaken to determine the significance of TiLV in the other countries. This report summarises the available scientific information on TiLV, including clinical signs, diagnostics and epidemiology. Infection with TiLV in tilapia populations may result in socio economic losses and impacts on food security.
Fact sheet: Tilapia lake virus (TiLV): What to know and do?
Tilapia lake virus is a newly emerging virus that is associated with significant mortalities in farmed tilapia. This fact sheet describes the threat to industry, clinical signs, diagnosis, risk factors, prevention and control options and actions that must be taken to minimise the impact of this disease on the global tilapia aquaculture industry. All countries with a tilapia industry must be vigilant and act quickly to investigate cases of mortalities in farms.
Urgent update on possible worldwide spread of tilapia lake virus (TiLV)
Recently, we released a warning of TiLV in Thailand and an improved RT-PCR detection methodology. The Fish Health Platform in Centex, BIOTEC/Mahidol University has also obtained positive test results for TiLV in other Asian countries where it has not yet been reported. Many countries have been translocating tilapia fry/fingerlings prior to and even after the description of TiLV. We have prepared a map listing countries with confirmed reports of TiLV infections and 43 other countries that we believe have imported infected fish.
Tilapia lake virus (TiLV) - a novel Orthomyxo-like virus
This disease card published by the World Organisation for Animal Health (OIE) provides information about tilapia lake virus (TiLV), a recently observed pathogen causing significant mortalities in cultured tilapia. The disease card provides details of the pathogen, modes of transmission, host range, geographical distribution, clinical signs, diagnostic methods, socio-economic significance, transmission risk and a list of available references. We urge laboratories to test for TiLV when abnormal tilapia mortalities occur.
Disease advisory: Tilapia lake virus - an emerging threat to farmed tilapia in the Asia-Pacific region
Tilapia lake virus (TiLV) is an emerging disease of cultured tilapia in the Asia-Pacific region. Originally observed and reported in Israel, Ecuador, Colombia and Egypt, TiLV is now confirmed in cultured tilapia in Thailand causing mass mortalities. At risk is here is the US$7.5 billion global industry per annum, especially among the top tilapia-producing countries in the region including China, the Philippines, Thailand, Indonesia, Lao PDR and Bangladesh. This advisory describes signs of the disease and PCR detection methods.
A warning and an improved PCR detection method for tilapia lake virus (TiLV) disease in Thai tilapia farms
Tilapia lake virus (TiLV) is an emerging virus that causes syncytial hepatitis of tilapia with mortalities of up to 90%. Recent disease outbreaks in Thai tilapia farms have been associated with high cumulative mortalities and histopathological features typical of SHT. Infection has now been confirmed. The semi-nested RT-PCR protocol described here may be used freely for non-commercial applications to detect TiLV. The authors urge laboratories in Asia to test for TiLV when abnormal tilapia mortality occurs.
A new and improved PCR detection method for Enterocytozoon hepatopenaei (EHP) based on a gene encoding a spore wall protein
Hepatopancreatic microsporidiosis (HPM) caused by Enterocytozoon hepatopenaei (EHP) is a newly emerging disease of cultivated shrimp in Asia. Current evidence indicates that it can be associated with severe growth retardation that may not be clearly evident until the second month of culture and may cause low continuous mortality in the case of very severe infections. We present a new method for detecting EHP that has superior specificity to the first generation SSU-PCR developed in 2009.
Hepatopancreatic microsporidiosis caused by Enterocytozoon hepatopenaei: Disease card
This disease card describes the diagnosis and range of a microsporidian shrimp pathogen, Enterocytozoon hepatopenaei (EHP), first discovered in Penaeus monodon in Thailand in 2004. It infects only the tubule epithelial cells of the hepatopancreatic tissue of shrimp. EHP was later found to also infect P. vannamei cultivated in Thailand and is suspected to have been reported from P. japonicus in Australia in 2001. EHP has been reported from Vietnam and is associated with white faeces syndrome.
A two-tube, nested PCR detection method for AHPND bacteria
A new method for the detection of AHPND-bacteria (AP4) has been published and is available for download. The advantage of the AP4 method over the previously published AP3 method is that it has 100 times higher sensitivity. Because of its higher sensitivity, the bacterial culture enrichment step needed when using the AP3 with low levels of AHPND bacteria may be omitted. However, the AP4 method should not be considered as a replacement for AP3.